Artikels

Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis.

Authors: Markus Mayrhofer, Bram De Laere, Tom Whitington, Peter Van Oyen, Christophe Ghysel, Jozef Ampe, Piet Ost, Wim Demey, Lucien Hoekx, Dirk Schrijvers, Barbara Brouwers, Willem Lybaert, Els Everaert, Daan De Maeseneer, Michiel Strijbos, Alain Bols, Karen Fransis, Steffi Oeyen, Pieter-Jan van Dam, Gert Van den Eynden, Annemie Rutten, Markus Aly, Tobias Nordström, Steven Van Laere, Mattias Rantalainen, Prabhakar Rajan, Lars Egevad, Anders Ullen, Jeffrey Yachnin, Luc Dirix, Henrik Grönberg, Johan Lindberg

Publicatiedatum: 2018/11/21

Tijdschrift: Genome medicine

Circulating tumor cells and survival in abiraterone‐ and enzalutamide‐treated patients with castration‐resistant prostate cancer.

Contributors: Bram De Laere; Steffi Oeyen; Peter Van Oyen; Christophe Ghysel; Jozef Ampe; Piet Ost; Wim Demey; Lucien Hoekx; Dirk Schrijvers; Barbara Brouwers et al.

The Prostate 2018-05 | Journal articleDOI: 10.1002/pros.23488

Perceived role of social media in urologic knowledge acquisition among young urologists: a European survey.

Authors: Gómez Rivas JA, Rodriguez Socarras ME, Patruno G, Uvin P, Esperto F, Dinis PJ, Roupret M, Borgmann H (2018).  

European Urology Focus 4(5):768-73.

Fatigue syndrome: Stress, Burnout and Depression in Urology.

Authors: Rodriguez-Socarras M, Vasquez JL, Uvin P, Skjold-Kingo P, Gomez Rivas J (2018).  

Arch Esp Urol 71(1) :46-54

The use of fosfomycin as targeted antibiotic prophylaxis before prostate biopsy: a prospective randomized cohort study.

Authors: Van Besien J, Uvin P, Weyne E, Van Praet C, Merckx L, De Graeve N, van Renterghem K, Cartuyvels R, Van den Abeele AM (2018).  

International Journal of Urology 26(3):391-7.

Androgen receptor burden and poor response to abiraterone or enzalutamide in TP53 wild-type metastatic castration-resistant prostate cancer.

Authors: De Laere B; Rajan P; Gronberg H; Dirix L; Lindberg J; Mayrhofer M; Whitington T; van Dam P-J; Van Oyen P; Ghysel C; Ampe J; Ost P; Demey W; Hoela L; Schrijvers D; Brouwers B; Lybaert W; Everaert E; De Maeseneer D; Strijbos M; Bols A; Fransis K; Beije N; de Kruijff I; van Dam V; Brouwer A; Goossens D; Heyrman L; Van den Eynden G; Rutten A; Del Favero J; Rantalainen M; Sleijfer S; Ullen A; Yachnin J; Van Laere S; De laere L; Develter T; Vantieghem S; Herman S; Coifs G; Lamotte V; Boumans A; Baitar A; Haeck R; Wallays G

Tijdschrift: JAMA Oncology (2019)

Time to Move On: The Impending Need for a New Disease-specific Comorbidity Index for Bladder Cancer Patients Undergoing Robot-assisted Radical Cystectomy.

Authors: Lambert E, D'Hondt F, Mazzone E, Vollemaere J, Larcher A, Van Der Jeugt J, Devos G, Uvin P, Goossens M, Poelaert F, De Naeyer G, Schatteman P, Collins J, Mottrie A, Dell'Oglio P (2019).  

European Urology Focus 7(1) :139-41.

Lifestyle among urology trainees and young urologist in the context of burn-out syndrome.

Authors: Rodríguez-Socarrás M, Skjold Kingo P, Uvin P, Østergren P, Patruno G, Edison E, Kasivisvanathan V, Vásquez JL, Esperto F, Gómez Rivas J (2020).  

Actas Urol Esp 44(1):19-26.

TRPV4 Mediates Acute Bladder Responses to Bacterial Lipopolysaccharides.

Authors: Alpizar YA, Uvin P, Naert R, Franken J, Pinto S, Sanchez A, Gevaert T, Everaerts W, Voets T, De Ridder D and Talavera K (2020). 

Front. Immunol 11:799. Article DOI: 10.3389/fimmu.2020.00799.

Phase II open-label study investigating apalutamide in patients with biochemical progression after radical prostatectomy.

Authors: Dirix P, Strijbos M, den Mooter TV, Liefhooghe N, Bruwaene SV, Uvin P, Ghysel C, Ost D, Schatteman P, Bral S, Engels B, den Begin RV, Otte FX, Roumeguere T, Palumbo S, Neybuch Y, Fonteyne V, Ost P, Dirix L (2020).  

Future Oncology 16(16):1083-9.

Undergraduate Education for Urology in Europe. Where do we stand?

Authors: Gómez Rivas J, Rodríguez-Socarrás M, Somani B, Uvin P, Vasquez JL, Henningsohn L, Pearce I, Zondervan P, Van Poppel H, Palou J (2020).  

European Urology 78(3):381-4.

Increased pathway complexity is a prognostic biomarker in metastatic castration-resistant prostate cancer. 

Authors: Bram De Laere (UGent) , A Crippa, A Mortezavi, C Ghysel, P Rajan, M Eklund, A Wyatt, L Dirix, Piet Ost (UGent) , H Grönberg, et al. (2021) 

CANCERS. 13 (7).

The Effect of Surgical Experience on Perioperative and Oncological Outcomes After Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion: Evidence from a Referral Centre with Extensive Experience in Robotic Surgery.

Authors: Dell'Oglio P, Mazzone E, Lambert E, Vollemaere J, Goossens M, Larcher A, Van Der Jeugt J, Devos G, Poelaert F, Uvin P, Collins J, De Naeyer G, Schatteman P, D'Hondt F, Mottrie A (2021). 

Eur Urol Focus 7(2):352-8.

Time to Move On: The Impending Need for a New Disease-specific Comorbidity Index for Bladder Cancer Patients Undergoing Robot-assisted Radical Cystectomy.

Authors: Lambert E, D'Hondt F, Mazzone E, Vollemaere J, Larcher A, Van Der Jeugt J, Devos G, Uvin P, Goossens M, Poelaert F, De Naeyer G, Schatteman P, Collins J, Mottrie A, Dell'Oglio P (2021).  

European Urology Focus 7(1):139-141.

Irrigation fluid absorption syndrome during HoLEP: A case study.

Authors: Slots C, Uvin P, Van Damme E (2022).  

Urology Case Rep 3;45:102248.

Safety and efficacy of software-assisted MRI-TRUS fusion-guided transperineal prostate biopsy in an outpatient setting using local anaesthesia.

Authors: De Vulder N, Slots C, Geldof K, Ramboer K, Dekimpe P, Uvin P, Walgraeve MS, Van Holsbeek A, Gieraerts K (2022).  

Abdom Radiol 48(2):694-703.

Discrimination, Reliability, Sensitivity, and Specificity of Robotic Surgical Proficiency Assessment With Global Evaluative Assessment of Robotic Skills and Binary Scoring Metrics: Results From a Randomized Controlled Trial.

Authors: De Groote R, Puliatti S, Amato M, Mazzone E, Larcher A, Farina R, Paludo A, Desender L, Hubert N, Van Cleynenbreugel B, Bunting B, Mottrie A, Gallagher A, Rosiello G, Uvin P, Decoene J, Tuyten T, D'hondt M, Chatzopoulos C, De Troyer B, Turri F, Dell'Oglio P, Liakos N, Bravi C, Lambert E, Andras I, Di Maida F, Everaerts W (2023).  

Ann Surg Open 16(5): e307.

Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial.

Authors: De Laere B; Crippa A; Discacciati A; Larsson B; Persson M; Johansson S; D'hondt S; Bergstrom R; Chellappa V; Mayrhofer M; Banijamali M; Kotsalaynen A; Schelstraete C; Vanwelkenhuyzen JP; Hjalm-Eriksson M; Pettersson L; Ullen A; Lumen N; Enblad G; Thellenberg Karlsson C; Janes E; Sandzen J; Schatteman P; Vigmostad M; Olsson M; Ghysel C; Sautois B; De Roock W; Van Bruwaene S; Anden M; Verbiene I; De Maeseneer D; Everaert E; Darras J; Aksnessether BY; Luyten D; Strijbos M; Mortezavi A; Oldenburg J; Ost P; Eklund M; Gronberg H; Lindberg J

NATURE MEDICINE. 2024 Nov;30(11):3291-3302.doi: 10.1038/s41591-024-03204-2. Epub 2024 Aug

Androgen deprivation therapy in advanced prostate cancer : insights from a real-world patient survey on health-related quality of life and information and communication sources.

Authors: Renée Bultijnck (UGent), Luc De Laere, Rony De Grande, Thijs Develter, Sophie Vantieghem, Pieter Uvin, Christophe Ghysel, Bram De Laere(UGent) and the patient organization Think Blue Vlaanderen vzw (2024) 

QUALITY OF LIFE RESEARCH. 33(9). p.2553-2562

TAR-200 for Bacillus Calmette-Guérin-Unresponsive High-Risk Non-Muscle-Invasive Bladder Cancer: Results From the Phase IIb SunRISe-1 Study.

Authors: Siamak Daneshmand et al.

Collaborator: Dr. Frederic Baekelandt

J Clin Oncol. 2025. 

RE: transurethral resection of the prostate across continents: a meta-analysis evaluating quality of gold standard in the twenty-first century.

Authors: Chea MS, Keller EX, Uvin P, De Coninck V (2025). 

World J Urol 7;43(1):281.

Paratesticular liposarcomas: A rare but crucial diagnosis. Case series and review of literature. 

Authors: Pieter De Rop 1 , Frederic Baekelandt 1.

Cent European J Urol. 2025;78(3):318-322. - doi: 10.5173/ceju.2025.0003. Epub 2025 Aug 31.

Feasibility of randomisation to radical prostatectomy or standard care in patients with metastatic prostate cancer.

Authors: Van den Eynde L, Ost P, Verla W, Everaerts W, Fransis K, Uvin P, Ameye F, Van Erps T, Fonteyne V, Van Praet C, Lumen C (2025).  

BJUI 136(6):1121-1127.

Transperitoneal versus retroperitoneal approach does not alter arterial clamping strategy during robot-assisted partial nephrectomy: interim results from the multicentric PODRACING randomized controlled trial. 

Authors: Vangeneugden J, Vermijs S, De Kuyper P, Berquin C, Lumen N, Declerck V, Baekelandt F, Ghysel C, Raskin Y, Bynens B, Mestdagh K, De Backer P, De Visschere P, Debbaut C, Van Praet C and Decaestecker K (2026).

Front. Oncol. 16:1767578. doi: 10.3389/fonc.2026.1767578.

Robotic-assisted resection of parametrial endometriosis with ureterolysis of a medially distorted ureter using indocyanine green and near-infrared fluorescence.

Authors: Philippe Van Trappen, Gaby Moawad, Christophe Ghysel and Harm Arentsen (2026)

Journal of Surgical Case Reports, 2026, 1, rjaf1064.

Clinical trial protocol of PODRACING: A randomized controlled trial evaluating 3D perfusion zone models for selective arterial clamping during robot-assisted partial nephrectomy.

Authors: Joris Vangeneugden, Saar Vermijs, Pieter De Backer, Camille Berquin, Nicolaas Lumen, Peter De Kuyper, Yannic Raskin, Bernard Bynens, Frederic Baekelandt, Christophe Ghysel, Frederick Peeren, Ruben De Groote, Geert De Naeyer, Alexandre Mottrie, Stefanie De Buyser, Pieter De Visschere, Charlotte Debbaut, Karel Decaestecker and Charles Van Praet.

BJUI Compass - First published: 30 March 2026 

https://doi.org/10.1002/bco2.70191